Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

To Decrease Fatigue With Light Therapy

NCT03242902

Conditions
Diffuse Large B Cell Lymphoma, Dyssomnias, Hemic and Lymphatic Diseases, +17 more
Locations
  • Radboudumc Nijmegen, Gelderland, Netherlands
  • Netherlands Cancer Institute Amsterdam, North Holland, Netherlands
  • VUmc Amsterdam, North Holland, Netherlands
  • Leids Universitair Medisch Centrum Leiden, South Holland, Netherlands
View Trial Details
Completed

Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma

NCT00570180

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
  • CancerCare Manitoba 675 McDermot Ave. Winnipeg, Manitoba, Canada
  • Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
  • London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada
View Trial Details
Completed

Zevalin-beam for Aggressive Lymphoma

NCT00491491

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

NCT02343536

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions